{
    "clinical_study": {
        "@rank": "159945", 
        "arm_group": [
            {
                "arm_group_label": "Polymeric nutritional supplement", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Standard Nutritional Treatment", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "Patient found to be malnourished after the nutritional evaluation would be randomized in the\n      two groups of the study. The control group would receive standard nutritional counseling\n      from a trained dietician where as those in the intervention group would be given 120 gm of a\n      polymeric nutritional supplement providing around 500 Kcal per day over and above the\n      standard nutritional counseling from a trained dietician.  Both the groups would receive\n      standard medical treatment. The polymeric nutrient supplement would be taken by the patients\n      in this arm for a period of 6 months."
        }, 
        "brief_title": "Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease", 
        "completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Alcoholic Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Liver Diseases", 
                "Liver Diseases, Alcoholic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with ALD (Alcoholic Liver Disease) would undergo a detailed clinical evaluation.\n      Information would be collected regarding the onset and duration of symptoms, etiology, and\n      severity of disease, other baseline clinical features, demographic characteristics,  routine\n      biochemical and hematological investigations, upper GI endoscopic findings and radiological\n      investigations, patients would also be screened for the assessment of nutritional status.\n      Patient found to be malnourished after the nutritional evaluation would be randomized in the\n      two groups of the study. The control group would receive standard nutritional counseling\n      from a trained dietician where as those in the intervention group would be given 120 gm of a\n      polymeric nutritional supplement providing around 500 Kcal per day over and above the\n      standard nutritional counseling from a trained dietician.  Both the groups would receive\n      standard medical treatment. The polymeric nutrient supplement would be taken by the patients\n      in this arm for a period of 6 months. A record would be kept for the medications taken by\n      the patients.\n\n      All the patients would be followed up at 1 week, 2 weeks, 3 weeks, 1 month, 2 months, 3\n      months, 6 months, and 1 year after inclusion. Clinical, nutritional and biological data were\n      collected at each visit. All these patients would receive standard treatment of cirrhosis\n      consisting of withdrawal from alcohol along with symptomatic treatment including B vitamins,\n      diuretics, salt restriction, lactulose, beta blockers, and antibiotics after bacteriological\n      samples if needed. All patients would receive endoscopic surveillance for portal\n      hypertension. An adequate prophylaxis by ligation or beta blockers would be performed as\n      needed. The patients with a past history of spontaneous bacterial peritonitis will receive\n      antibiotic prophylaxis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All consecutive malnourished patients with ALD aged between 18 to 65 years of either\n             gender would be enrolled.\n\n          -  Abstinence of three months.\n\n        Exclusion Criteria:\n\n          -  Severe alcoholic hepatitis\n\n          -  Uncontrolled complication of the cirrhosis (variceal bleeding, infection, etc.),\n\n          -  Hepatocellular carcinoma\n\n          -  Ongoing corticosteroid treatment\n\n          -  Co morbidities e.g. chronic renal insufficiency, Diabetes mellitus, Hypertension &\n             Acquired immunodeficiency syndrome.\n\n          -  Refusal to participate in the trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "856", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02140294", 
            "org_study_id": "ILBS-NA-ALD-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Polymeric nutritional supplement", 
                "intervention_name": "Polymeric nutritional supplements", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Standard Nutritional Treatment", 
                "intervention_name": "Standard Nutrional Treatment", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 15, 2014", 
        "location": {
            "contact": {
                "email": "dr.chetankalal@gmail.com", 
                "last_name": "Dr Chetan Kalal, MD", 
                "phone": "011-46300000"
            }, 
            "facility": {
                "address": {
                    "city": "New Delhi", 
                    "country": "India", 
                    "state": "Delhi", 
                    "zip": "110070"
                }, 
                "name": "Institute of Liver & Biliary Sciences"
            }, 
            "investigator": {
                "last_name": "Dr Chetan Kalal, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "Long Term Effect of Aggressive Nutritional Management on Survival in Patients With Alcoholic Liver Disease - A Randomized Control Trial", 
        "overall_contact": {
            "email": "dr.chetankalal@gmail.com", 
            "last_name": "Dr Chetan Kalal, MD", 
            "phone": "011-46300000"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To assess the effect of nutritional therapy on overall  survival", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02140294"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Nutritional Status will be measured by Royal Free Hospital-Global Assessment (RFH-GA) method.", 
                "measure": "To assess the effect of nutritional therapy on nutritional status", 
                "safety_issue": "No", 
                "time_frame": "1 Year"
            }, 
            {
                "measure": "To assess the effect of nutritional therapy on hepatic morbidity (appearance or failure of resolution of ascites, appearance of gastrointestinal bleeding, appearance of hepatic encephalopathy, development of infection and acute kidney injury)", 
                "safety_issue": "No", 
                "time_frame": "1 Year"
            }, 
            {
                "measure": "To assess the effect of nutritional therapy on Health-related quality of life", 
                "safety_issue": "No", 
                "time_frame": "1 Year"
            }
        ], 
        "source": "Institute of Liver and Biliary Sciences, India", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institute of Liver and Biliary Sciences, India", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}